Credit Suisse’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $194K | Sell |
|
|||||
|
2023
Q1 | $594K | Buy |
|
|||||
|
2022
Q4 | $483K | Buy |
|
|||||
|
2022
Q3 | $760K | Buy |
|
|||||
|
2022
Q2 | $626K | Buy |
|
|||||
|
2022
Q1 | $1.02M | Buy |
|
|||||
|
2021
Q4 | $398K | Sell |
|
|||||
|
2021
Q3 | $498K | Buy |
|
|||||
|
2021
Q2 | $866K | Sell |
|
|||||
|
2021
Q1 | $945K | Sell |
|
|||||
|
2020
Q4 | $3.31M | Sell |
|
|||||
|
2020
Q3 | $3.31M | Sell |
|
|||||
|
2020
Q2 | $4.44M | Buy |
|
|||||
|
2020
Q1 | $1.73M | Sell |
|
|||||
|
2019
Q4 | $2.18M | Buy |
|
|||||
|
2019
Q3 | $403K | Sell |
|
|||||
|
2019
Q2 | $572K | Sell |
|
|||||
|
2019
Q1 | $603K | Buy |
|
|||||
|
2018
Q4 | $618K | Buy |
|
|||||
|
2018
Q3 | $784K | Sell |
|
|||||
|
2018
Q2 | $796K | Buy |
|
|||||
|
2018
Q1 | $619K | Buy |
|
|||||
|
2017
Q4 | $384K | Buy |
|
|||||
|
2017
Q3 | $352K | Buy |
|
|||||
|
2017
Q2 | $97K | Sell |
|
|||||
|
2017
Q1 | $197K | Sell |
|
|||||
|
2016
Q4 | $168K | Sell |
|
|||||
|
2016
Q3 | $242K | Buy |
|
|||||
|
2016
Q2 | $134K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $630K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.7M | Buy |
|
|||||
|
2015
Q1 | $903K | Buy |
|
|||||
|
2014
Q4 | $685K | Buy |
|
|||||
|
2014
Q3 | $273K | Buy |
|
|||||
|
2014
Q2 | $282K | Sell |
|
|||||
|
2014
Q1 | $380K | Buy |
|